{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:20:51Z","timestamp":1765254051545,"version":"3.44.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.taap.2020.115074","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T20:33:33Z","timestamp":1590438813000},"page":"115074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In silico, in vitro and in vivo evaluation of natural Bignoniaceous naphthoquinones in comparison with atovaquone targeting the selection of potential antimalarial candidates"],"prefix":"10.1016","volume":"401","author":[{"given":"Maria Fernanda Alves","family":"do Nascimento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiane Freitas","family":"Borgati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Camila Ribeiro","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Tagliati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0374-8909","authenticated-orcid":false,"given":"Ala\u00edde Braga","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115074_bb0005","doi-asserted-by":"crossref","DOI":"10.2174\/1874848100902010042","article-title":"Preclinical and clinical studies of lapachol and beta-lapachone","volume":"2","author":"Almeida","year":"2009","journal-title":"Open Nat. Prod. J."},{"key":"10.1016\/j.taap.2020.115074_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-8741(90)90061-W","article-title":"Antiinflammatory action of lapachol","volume":"29","author":"Almeida","year":"1990","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bmcl.2003.12.069","article-title":"Antimalarial activity of phenazines from lapachol, \u03b2-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo","volume":"14","author":"Andrade-Neto","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.taap.2020.115074_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tmaid.2019.01.008","article-title":"The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: a systematic review","volume":"27","author":"Andrejko","year":"2019","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.taap.2020.115074_bb0025","first-page":"57","article-title":"Lapachol: seguran\u00e7a e efic\u00e1cia na terap\u00eautica","volume":"12","author":"Ara\u00fajo","year":"2002","journal-title":"Rev. Bras"},{"key":"10.1016\/j.taap.2020.115074_bb0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.fct.2014.07.037","article-title":"Toxicological in vitro and subchronic evaluation of LASSBio-596","volume":"73","author":"Ara\u00fajo","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2020.115074_bb0035","first-page":"1152","article-title":"Recherches sur un nouvel acide extrait du bois de taigu du Paraguay","volume":"46","author":"Arnaudon","year":"1858","journal-title":"Compt. Rend."},{"key":"10.1016\/j.taap.2020.115074_bb0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AAC.46.5.1163-1173.2002","article-title":"Antiparasitic agent atovaquone","volume":"46","author":"Baggish","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"author":"Bioinformatics and Molecular Design Research Center","key":"10.1016\/j.taap.2020.115074_bb0045"},{"key":"10.1016\/j.taap.2020.115074_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7496934","article-title":"Synthesis, SAR, and docking studies disclose 2-Arylfuran-1, 4-naphthoquinones as in vitro antiplasmodial hits","volume":"2017","author":"Borgati","year":"2017","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.taap.2020.115074_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/ci600376q","article-title":"Reaction site mapping of xenobiotic biotransformations","volume":"47","author":"Boyer","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2020.115074_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds","volume":"145","author":"Brand\u00e3o","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.taap.2020.115074_bb0065","first-page":"485","article-title":"In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum","volume":"21","author":"Carvalho","year":"1988","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.taap.2020.115074_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2008.10.004","article-title":"Red Lapacho (Tabebuia impetiginosa)\u2014a global ethnopharmacological commodity?","volume":"121","author":"Castellanos","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1590\/S1415-47572010005000070","article-title":"Genotoxicity of lapachol evaluated by wing spot test of Drosophila melanogaster","volume":"33","author":"Costa","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.taap.2020.115074_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1521-4184(200212)335:9<427::AID-ARDP427>3.0.CO;2-M","article-title":"Synthesis and biological evaluation of cytotoxic 6 (7)-Alkyl-2-hydroxy-1, 4-naphthoquinones","volume":"335","author":"Del Corral","year":"2002","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.taap.2020.115074_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.40.3.556","article-title":"Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients","volume":"40","author":"Dixon","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2020.115074_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3565(25)03481-0","article-title":"Naphthoquinone antimalarials: XX. Metabolic degradation","volume":"94","author":"Fieser","year":"1948","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2020.115074_bb0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bmcl.2013.12.049","article-title":"Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives","volume":"24","author":"Fiorito","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.taap.2020.115074_bb0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 study of ARQ 761, a \u03b2-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2020.115074_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jphp.13029","article-title":"Antiplasmodial activity and cytotoxicity, isolation of active alkaloids, and dereplication of Xylopia sericea leaves ethanol extract by UPLC-DAD-ESI-MS\/MS","volume":"71","author":"Gontijo","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/ja01298a032","article-title":"Lomatiol. Part II. Its occurrence, constitution, relation to and conversion into Lapachol. Also a synthesis of Lapachol. 1, 2","volume":"58","author":"Hooker","year":"1936","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2020.115074_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00042560-199503010-00005","article-title":"The role of atovaquone tablets in treating Pneumocystis carinii pneumonia","volume":"8","author":"Hughes","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.taap.2020.115074_bb0120","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/13543776.2017.1339792","article-title":"Lapachol and lapachone analogs: a journey of two decades of patent research (1997-2016)","volume":"27","author":"Hussain","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.taap.2020.115074_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3998\/ark.5550190.0008.204","article-title":"Lapachol: an overview","volume":"2","author":"Hussain","year":"2007","journal-title":"Arkivoc."},{"key":"10.1016\/j.taap.2020.115074_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4196\/kjpp.2013.17.1.9","article-title":"Impact of micellar vehicles on in situ intestinal absorption properties of beta-lapachone in rats","volume":"17","author":"Jang","year":"2013","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0135","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1039\/c3cc40432c","article-title":"Organometallic anticancer complexes of lapachol: metal CENTRE-dependent formation of reactive oxygen species and correlation with cytotoxicity","volume":"49","author":"Kandioller","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.taap.2020.115074_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/phrs.2000.0791","article-title":"Aminonaphthoquinones\u2014a novel class of compounds with potent antimalarial activity against Plasmodium falciparum","volume":"43","author":"Kapadia","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2020.115074_bb0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00280-013-2230-x","article-title":"Effects of \u03b2-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism","volume":"72","author":"Kim","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4062\/biomolther.2015.029","article-title":"Preclinical pharmacokinetic evaluation of \u03b2-lapachone: characteristics of oral bioavailability and first-pass metabolism in rats","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.taap.2020.115074_bb0155","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.3390\/molecules190914902","article-title":"1, 4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling","volume":"19","author":"Klotz","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2020.115074_bb0160","first-page":"899","article-title":"Prediction of in-silico ADME properties of 1, 2-O-isopropylidene aldohexose derivatives","volume":"13","author":"Kova\u010devi\u0107","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.taap.2020.115074_bb0165","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"418\u2013420","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.taap.2020.115074_bb0170","first-page":"13053","article-title":"A phase Ib trial of ARQ 501, a selective checkpoint activator, in combination with docetaxel in patients with advanced solid tumors.J","volume":"24","author":"Li","year":"2006","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.taap.2020.115074_bb0175","first-page":"12","article-title":"Primeiras observa\u00e7\u00f5es sobre a a\u00e7\u00e3o antimicrobiana do lapachol","volume":"4","author":"Lima","year":"1956","journal-title":"Rev. Inst. Antibi\u00f3t."},{"key":"10.1016\/j.taap.2020.115074_bb0180","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3109\/03639048509057698","article-title":"Some formulation properties of Lapachol, a potential oncolytic agent of natural origin","volume":"11","author":"Lui","year":"1985","journal-title":"Drug Dev.Ind. Pharm."},{"key":"10.1016\/j.taap.2020.115074_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2014.12.027","article-title":"Esterase-activatable \u03b2-lapachone prodrug micelles for NQO1-targeted lung cancer therapy","volume":"200","author":"Ma","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2020.115074_bb0190","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1055\/s-0029-1240816","article-title":"Lapachol induces clastogenic effects in rats","volume":"76","author":"Maistro","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.taap.2020.115074_bb0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0169-4758(98)01284-8","article-title":"Lactate dehydrogenase and the diagnosis of malaria","volume":"14","author":"Makler","year":"1998","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.taap.2020.115074_bb0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejmech.2016.11.025","article-title":"Comprehensive review on various strategies for antimalarial drug discovery","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2020.115074_bb0205","first-page":"52","article-title":"Antimalarial natural products: a review","volume":"2","author":"Mojab","year":"2012","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.taap.2020.115074_bb0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.intimp.2006.12.006","article-title":"Anti-inflammatory effects of \u03b2-lapachone in lipopolysaccharide-stimulated BV2 microglia","volume":"7","author":"Moon","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/14756366.2014.958083","article-title":"Evaluation of naphthoquinones identified the acetylated isolapachol as a potent and selective antiplasmodium agent","volume":"30","author":"Moreira","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.taap.2020.115074_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(70)90126-2","article-title":"Oral toxicology studies with lapachol","volume":"17","author":"Morrison","year":"1970","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.taap.2020.115074_bb0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jep.2018.09.012","article-title":"In vitro antiplasmodial activity and identification, using tandem LC-MS, of alkaloids from Aspidosperma excelsum, a plant used to treat malaria in Amazonia","volume":"228","author":"Nascimento","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0235","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/b810413a","article-title":"Characterization, reactivity and photosensitizing properties of the triplet excited state of \u03b1-lapachone","volume":"10","author":"Netto-Ferreira","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.taap.2020.115074_bb0240","series-title":"Acute Oral Toxicity e Acute Toxic Class Method: Test No-423","article-title":"Guideline for the testing of chemicals","author":"OECD","year":"2001"},{"key":"10.1016\/j.taap.2020.115074_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S0001-37652002000200004","article-title":"New enamine derivatives of lapachol and biological activity","volume":"74","author":"Oliveira","year":"2002","journal-title":"Na. Acad. Bras. Ci\u00eanc."},{"key":"10.1016\/j.taap.2020.115074_bb0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/S0001-37652009000400011","article-title":"Plant-derived antimalarial agents: new leads and efficient phythomedicines. Part I. Alkaloids","volume":"81","author":"Oliveira","year":"2009","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.taap.2020.115074_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13318-016-0337-2","article-title":"Inactivation of \u03b2-lapachone cytotoxicity by filamentous fungi that mimic the human blood metabolism","volume":"42","author":"Paludo","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2020.115074_bb0260","first-page":"337","article-title":"Ricerche sull\u2019acido lapacico","volume":"12","author":"Patern\u00f3","year":"1882","journal-title":"Gazz. Chim. Ital."},{"key":"10.1016\/j.taap.2020.115074_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13075-017-1236-x","article-title":"Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis","volume":"19","author":"Peres","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.taap.2020.115074_bb0270","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cbdv.200590009","article-title":"Antiplasmodial activity of naphthoquinones related to lapachol and \u03b2-lapachone","volume":"2","author":"P\u00e9rez-Sacau","year":"2005","journal-title":"Chem. Biodivers."},{"year":"1873","author":"Pinto","key":"10.1016\/j.taap.2020.115074_bb0275"},{"key":"10.1016\/j.taap.2020.115074_bb0280","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.3390\/molecules14114570","article-title":"The trypanocidal activity of naphthoquinones: a review","volume":"14","author":"Pinto","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2020.115074_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2125.1994.tb04232.x","article-title":"Examination of some factors responsible for a food-induced increase in absorption of atovaquone","volume":"37","author":"Rolan","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0290","first-page":"89","article-title":"Observa\u00e7\u00f5es sobre as propriedades antitumorais e toxicol\u00f3gicas do extrato do l\u00edber e de alguns componentes do cerne do Pau d\u2019arco (Tabebuia avellanedae)","volume":"8","author":"Santana","year":"1968","journal-title":"Rev Inst Antib"},{"issue":"16","key":"10.1016\/j.taap.2020.115074_bb0295","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/jco.2005.23.16_suppl.3042","article-title":"Phase I trial of ARQ 501, an activated checkpoint therapy (ACT) agent, in patients with advanced solid tumors","volume":"23","author":"Shapiro","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2020.115074_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1386207053328129","article-title":"The role of in vitro ADME assays in antimalarial drug discovery and development","volume":"8","author":"Shearer","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.taap.2020.115074_bb0305","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1590\/0074-0276130603","article-title":"Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies","volume":"109","author":"Souza","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.taap.2020.115074_bb0310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dkx431","article-title":"Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis","volume":"73","author":"Staines","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.taap.2020.115074_bb0315","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4161\/cc.5.17.3312","article-title":"Selective induction of necrotic cell death in cancer cells by \u03b2-lapachone through activation of DNA damage response pathway","volume":"5","author":"Sun","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.taap.2020.115074_bb0320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2012.12.048","article-title":"Cytotoxicity of lapachol, \u03b2-lapachone and related synthetic 1, 4-naphthoquinones against oesophageal cancer cells","volume":"62","author":"Sunassee","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2020.115074_bb0325","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.taap.2020.115074_bb0330","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"In silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2020.115074_bb0335","first-page":"155","article-title":"Controle de qualidade f\u00edsico-qu\u00edmico e legalidade de mat\u00e9ria-prima vegetal e produto acabado contendo ip\u00ea-roxo (Tabebuia sp.)","volume":"92","author":"Vasconcelos","year":"2011","journal-title":"Rev. Bras"},{"key":"10.1016\/j.taap.2020.115074_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0076-6879(04)78004-0","article-title":"Redox cycling of \u03b2-Lapachone and structural analogues in microsomal and cytosol liver preparations","volume":"378","author":"Villamil","year":"2004","journal-title":"Methods Enzymol."},{"year":"2018","series-title":"World Health Organization. World malaria report 2018","author":"WHO","key":"10.1016\/j.taap.2020.115074_bb0345"},{"year":"2018","series-title":"Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy: Status Report","author":"World Health Organization","key":"10.1016\/j.taap.2020.115074_bb0350"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:50:45Z","timestamp":1758574245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20301988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":70,"alternative-id":["S0041008X20301988"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115074","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico, in vitro and in vivo evaluation of natural Bignoniaceous naphthoquinones in comparison with atovaquone targeting the selection of potential antimalarial candidates","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115074"}}